August 19th 2025
The study included the screening of 9857 drivers in 8 Indian states at automative shops and transit hubs.
AOA 2024: How to support patients who are receiving intravitreal injections
Rafieetary emphasizes the importance of follow-up plans and consistent support to prevent patients from dropping out of treatment, which can negatively impact their prognosis.
World Health Assembly panel to shine light on global pervasiveness of uncorrected refractive error
May 24th 2024Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.
Bipartisan proposal to US House aims to establish grants for pediatric eye care
May 16th 2024The Early Detection of Vision Impairment in Children (EDVI) Act was recently introduced in the US House of Representatives with the goal of improving access, diagnosis, and treatment for children ages 2 to 17, according to Prevent Blindness.
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.